Stock Taper
SCREENER
COMPARE ANY 2 STOCKS
Pricing
Log In
SIGN UP
EARNINGS CALL ARCHIVE
4 CALLS ON FILE
ETON
— Eton Pharmaceuticals, Inc.
NASDAQ
FULL STOCK PAGE →
Q4 2025 Earnings Call Summary
MAR 19, 2026
REVENUE
$21.3M
-5.2%
NET MARGIN
7.0%
+15.5 PTS
EPS
$0.06
+178.6%
FREE CASH FLOW
-$11.6M
-198.8%
No summary has been written for this call yet.
← NEWER CALL
CALL 3 OF 4
OLDER CALL →